MHRA approves first lower-carbon beclometasone inhalers for asthma
Research and Development MHRA, asthma, inhaler, lower carbon
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the world’s first pressurised metered dose inhalers (pMDIs) to use …
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
July 23, 2026CDMO, PolyPeptide, Samsung BioLogics, acquisition
Samsung Biologics has launched an all-cash public tender offer to acquire PolyPeptide Group in a deal valued at approximately CHF1.46bn, …
Novogenia breaks ground on personalised healthcare campus
July 23, 2026Research and Development Novogenia, R&D, healthcare, laboratory
Novogenia AG has broken ground on a new headquarters and laboratory campus in Hallwang, Austria, designed to expand its capabilities …
InfectoPharm launches Polish operations with first hospital antibiotic
July 22, 2026InfectoPharm, Polish subsidiary, hospital antibiotic
German pharmaceutical company InfectoPharm has officially launched its Polish subsidiary, marking its entry into the country’s pharmaceutical market with the …
FibroFind appoints Lee Borthwick as CEO
July 21, 2026FibroFind
FibroFind, a preclinical Contract Research Organisation has appointed Lee Borthwick as CEO, as the company begins its next phase of …
STADA appoints Mark Pearson as Head and EVP, Global Consumer Healthcare
July 20, 2026Stada
STADA has appointed former Reckitt executive Mark Pearson as Head and Executive Vice-President (EVP), Global Consumer Healthcare. Pearson, who also …
Care Quality Commission appoints Emily Miles as Chief Executive
July 17, 2026Care Quality Commission (CQC)
The Care Quality Commission (CQC) has appointed Emily Miles as Chief Executive. Miles joins CQC from her current role as …
National survey aims to improve glaucoma care across the UK
July 16, 2026Glaucoma UK, Opthalmology
Glaucoma UK has launched the National Patient Voices Survey, a nationwide study designed to capture the experiences of around 10,000 …
Phase 3 trials support expanded use of Dysport for migraine prevention
July 15, 2026Research and Development Dysport, ipsen, migraine prevention
Ipsen has reported positive topline results from its phase 3 BEOND clinical programme evaluating Dysport (abobotulinumtoxinA) for the prevention of …
Roche secures CE Mark for automated latent tuberculosis blood test
July 14, 2026Research and Development Roche, tuberculosis infection
Roche has received CE Mark approval for its Elecsys IGRA TB test, an automated blood test designed to improve the …
ReproNovo Phase 2 fertility study doses first participant
July 10, 2026Research and Development ReproNovo, fertility study
ReproNovo has dosed the first participant in its phase 2 NORDIC study evaluating RPN-002, an investigational therapy designed to improve …
Halma acquires pathology automation specialist Dreampath
July 9, 2026Business Development Dreampath, Halma
Halma has agreed to acquire French diagnostics company Dreampath in a deal that will expand its pathology portfolio and strengthen …
Hormone study could support blood test for endometriosis
July 8, 2026Research and Development endometriosis
Researchers at the University of Edinburgh have identified a distinct hormone profile associated with endometriosis that could lead to the …
Partnership aims to strengthen clinical research standards across MENA
July 7, 2026IAOCR, MARC
The International Accrediting Organization for Clinical Research (IAOCR) has partnered with MARC to support the adoption of international clinical research …
Cyllene raises €33m to advance genetic therapy for neuro-urology
July 6, 2026Research and Development neuro-urology
Cyllene Therapeutics has raised €33m in Series C financing to support later-stage development of EG110A, an investigational genetic medicine for …
Designing access: how a winning partnership delivered scalable change in primary care
July 2, 2026Business Services, Market Access Consultancy GP Pathfinder Clinics
As the UK healthcare system navigates a period of significant change, the path to successful market access is becoming increasingly …
Probi marks 35 years of probiotic research
July 2, 2026Probi
Probi is marking its 35th anniversary alongside a milestone of more than 300 scientific publications supporting the benefits of its …
Funding to advance antimicrobial therapy for drug-resistant pneumonia
July 1, 2026Telum Therapeutics, pneumonia
Telum Therapeutics has raised €18m in Series A financing to advance its lead antimicrobial programme into phase 1 clinical development …
Mallia secures €3m to expand hormone-free hair loss products
June 30, 2026Research and Development Mallia Innovations, hair loss
Mallia Innovations has raised €3m to support the European expansion of its hormone-free hair growth products and prepare for potential …
Celerion expands Swiss bioanalytical laboratory capacity
June 29, 2026Research and Development bioanalytical laboratory
Celerion has expanded its bioanalytical laboratory in Zurich, Switzerland, to increase capacity for drug development programmes and support growing global …
Vedana emerges with $46m funding to advance next-generation migraine therapies
June 26, 2026Research and Development Vedana Therapeutics, migraine therapies
Vedana Therapeutics has emerged from stealth with $46m in Series A financing to support development of a pipeline of investigational …
Latest content
FibroFind appoints Lee Borthwick as CEO
